Authors
Latest:
Negotiating better managed care contractsJerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
Latest:
Looking at the scalp and nails during a skin exam is keyA presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Latest:
Take-Home PointsJoshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Latest:
Addressing Differences in Patient Engagement Across Racial and Ethnic GroupsThere are interesting differences in the ways patients of varying ethnicities and races engage with technology.
Latest:
Tax Increases Coming? What Physicians Need to Know About the Inflation Reduction ActThe sweeping legislation contains tax code reform, health care provisions and climate change action. What does it mean for physicians?
Latest:
Grant Program Accepting Applications, Seeks to Bridge Care Gap in Inflammatory DermatosesGrant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.
Latest:
Grow Your Practice With the Right Marketing and SEONicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
2021 Acne Updates: New Drugs and ResearchA presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.
Latest:
Cyltezo Biosimilar Launches Today in the USBoehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Latest:
The JAK Inhibitor Pipeline Builds in DermatologyEight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Latest:
Further Research Needed to Study Link Between AD and ADHDResearchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.
Latest:
Roflumilast Patient Selection for Plaque Psoriasis TreatmentExperts describe roflumilast patient selection for plaque psoriasis treatment.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
Gut Microbiome Can Affect Radiation Cancer TreatmentThe overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
Latest:
Future Directions in the Treatment of Atopic DermatitisAndrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.
Latest:
Key Takeaways on the Management of Atopic DermatitisPanelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
The Importance of Collaboration Between Mohs Surgeons and UrologistsCaleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MDWeiss is the managing director of dermatology at OM1, a data analytics company with a health care focus.
Latest:
Deucravacitinib: A Year in ReviewAs deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Latest:
BCC Patient Case ImpressionsSherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
